Lannett Co

General

Total Cases14
Active Cases--
Patents--
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L5
A
PTAB
L5
E
CAFC
L5
A

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
01/23/25
Report to the Commissioner of Patents and Trademarks. (lnb) (Entered: 01/23/2025)
01/23/25
CONSENT JUDGMENT. Signed by Judge Gregory B. Williams on 1/23/2025. (lnb) (Entered: 01/23/2025)
01/22/25
PROPOSED CONSENT JUDGMENT AND INJUNCTION, by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.. (Balick, Steven) (Entered: 01/22/2025)
12/31/24
SO ORDERED, re [8] Unopposed MOTION for Extension of Time to File Answer filed by Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd., Actelion Pharmaceuticals US, Inc. Signed by Judge Gregory B. Williams on 12/31/24. (jaa) (Entered: 12/31/2024)
12/17/24
Unopposed MOTION for Extension of Time to File Answer - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.. (Balick, Steven) (Entered: 12/17/2024)
10/24/24
WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.: For Lannett Company, Inc. waiver sent on 10/23/2024, answer due 12/23/2024. (Balick, Steven) (Entered: 10/24/2024)
10/23/24
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 10/23/2024)
10/18/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shinyaku Co., Ltd.. (scs) (Entered: 10/18/2024)
10/18/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (scs) (Entered: 10/18/2024)
10/18/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (scs) (Entered: 10/18/2024)